|
Diabetes
Marvlix can be used alone or in conjuction with other treatment to regulate blood sugar level. Marvlix has been clinically proven to be more effective than prescription drugs in blood sugar management.
There has been a lot of research done in the effect of Cordyceps on the blood glucose metabolism system. Diabetes is a serious problem, especially in countries with a Western diet.
Cordyceps has been tested in a number of animal and human studies for its potential as a blood sugar regulation agent. The results are convincing.
In one clinical study, 95% of the patients treated with 3 grams Cordyceps daily saw improvement in their blood sugar measurement, while the control group showed only 54% improvement with traditional treatment.
In one animal trial by Kiho in 2000, Cordyceps was found to lower blood sugar levels in genetically diabetic animals. Another animal trial by Dr. Zhao and his team in 2002 showed that Cordyceps improves blood glucose metabolism and increases insulin sensitivity in normal animals. In another 2002 animal study by Hao and Chen concluded that Cordyceps positively affect blood sugar metabolism in animals with chemically induced diabetes.Â
The common thread throughout all of these trials is the increase in insulin sensitivity and the increase in the livers' output of the glucose regulating enzymes. In short, it appears that regardless of the cause or classification, Cordyceps is a great treatment for diabetes, either as a single agent or in conjunction with other drugs.
In one clinical study, non-diabetic patients were treated with 3 grams Cordyceps daily. Researchers found that the normal blood sugar change curve was significantly flattened in the Cordyceps group. In other words, the blood sugar did not go as high after eating, and it did not drop down as low between meals. This study again proved that Cordyceps has the ability to regulate blood sugar level.
References
Jia-Shi Zhu, M.D., Ph.D. and James Rippe, M.D. (2004) Presented at the American Physiological Society's (APS) annual scientific conference, Experimental Biology 2003, held April 17-21, 2004, in Washington, D.C.
Shin KH, Lim SS, Lee S, Lee YS, Jung SH, Cho SY. (2003) Anti-tumour and immuno-stimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps spp. Phytother Res. 2003 Aug; 17(7):830-3.
Koh JH, Yu KW, Suh HJ, Choi YM, Ahn TS. (2002) Activation of macrophages and the intestinal immune system by an orally administered decoction from cultured mycelia of Cordyceps sinensis. Biosci Biotechnol Biochem, 2002 Feb; 66(2):407-11.
Smith, Rowen and Sullivan (2002), Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatment, May 2002; 106-141.
Hsu T. H., Shiao L. H., Hsiea C., and Chang D. M. 2002. A comparison of the chemical composition and bioactive ingredients of the Chinese medicinal mushroom DongChongXiaCao, its counterfeit and mimic, and fermented mycelium of Cordyceps sinensis. Food Chem, 78:463-469.
Wang, R., Xie, J., Ji, P., Li, S., Zhan, H., Xia, J., Sun, H., Lei, L., Yu, J., Wang, Y., Holliday, J., Clinical Trial report on Chronic Hepatitis treatment using Immune-Assist brand mushroom extract mixture in conjunction with the drug Lamivudine Wasser, S.P., (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol, 2002; 60:258-274.
Yue-Qin C, Ning W, Hui Z, Liang-Hu Q. (2002) Differentiation of medicinal Cordyceps species by rDNA ITS sequence analysis. Planta Med. 2002 Jul; 68(7):635-9.
Creadon, M. and Dam, J. (1996). " Drink up." Time (August 19): 55. a biologically active compound from cultures mycelia of Cordyceps and Isaria species. Phytochemistry, 22:2509-2512.
Gordon, D. (1993). : The rumored dope on Beijing's Women." Newsweek September 27): 63. Grey, P. and Barker, R. (1993). Cordyceps or plant eats animal! The Victorian Naturalist, 110:98-107.
Guan, Y.J., Hu, G., Hou, M., Jiang, H., Wang, X., and Zhang, C. (1992). Effect of Cordyceps sinensis on T- lymphocyte subsets in chronic renal railure. Chinese Journal of Integrated Medicine, 12:323, 338-339.
Guo, Y. Z. (1986). [Medicinal chemistry, pharmacology and clinical applications of fermented mycelia of Cordyceps sinensis and JinShuBao capsule]. Journal of Modern Diagnostics and Therapeutics, 1:60-65.
Guo QC, Zhang C. (1995) Clinical Observations of Adjunctive Treatment of 20 Diabetic Patients with JinSHuiBao Capsule. J Administration Traditional Chinese Medicine 1995; 5(suppl):22.
Bok JW, Lermer L, Chilton J, Klingeman HG, Towers GH., (1999) Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 1999 Aug; 51(7):891-8.
Chamberlain, M. (1996). Ethnomycological experiences in South West China. Mycologist, 10 (4):173-176.
Chang, H.M. and But, P.P.H. (Eds.) (1986). Pharmacology and Applications of Chinese Materia Medica, 1. Philadelphia, PA: World Scientific, pp. 410-413.
Chen, J.R., Yen, J.H., Lin, C.C., Tsai, W.J., Liu, W.J., Tsai, J.J., Lin, S.F., and Liu, H.W. (1993). The effects of Chinese herbs on improving survival and inhibiting anti-ads DNA antibody production in lupus mice. American Journal of Chinese Medicine, 21:257-262.Â
Chen K, Li C. (1993) Recent advances in studies on traditional Chinese anti-aging Materia Medica. J Tradit Chin Med 1993 Sep; 13(3):223-6.
Chen, S.Z. and Chu, J.Z. (1996). [NMR an IR studies on the characterization of cordycepin and 2'deoxyadenosine]. Zhongguo Kangshengsu Zaxhi, 21:9-12.Â
Hammerschmidt, D.E. (1980). Szechwan purpura. New England Journal of Medicine, 302:1191-1193.Â
Holliday, J., Cleaver, P., Loomis-Powers, M., and Patel, D., Analysis of Quality and Techniques for Hybridization of Medicinal Fungus Cordyceps sinensis, International Journal of Medicinal Mushrooms, Vol. 6, pp. 147-160 (2004).
Huang, Q., Li, D., Liang, J., Liao, S., and Liang S., (1991). [Weak polar chemical components in Cordyceps]. Journal of Chinese Medical Materials, 14:33-34.
Ikumoto, T., Sasaki, S., Namba, H., Toyama, R., Moritoki, H., and Mouri, T. (1991). [Physiologically active compounds in the extracts from tochukaso and cultured mycelia of Cordyceps and Isaria]. Yakugaku Zasshi, 111:504-509.
Huang , Y. et al (1987) Toxicology studies on cultured Cordyceps sinensis strain B414. Zhongchengyao Yanjiu 10:24-25 From Abstracts of Chinese Medicine, 2:321.
Chen, Y.Q., Wang, N., Qu, L., Li., T., and Zhang, W. (2001). Determination of the anamorph of Cordyceps sinensis inferred from the analysis of the ribosomal DNA internal transcribed spacers and 5.85 rDNA. Biochemical Systematics and Ecology, 29:597-607.Â
Kadota, S., Shima, T., and Kikuchi, T. ( 1986) [Steroidal components of "I-Tiam-Hong" and Cordyceps sinensis. Separation and identification by high-performance liquid chromatography]. Yakugaku Zasshi, 106:1092-1097.
Kiho, T., Tabata , H., Ukai, S., and Hara, C., (1986). A minor protein-containing galactomannan from a sodium carbonate extracted of Cordyceps sinensis. Corbohydrate Reseach, 156:189-197.
Kiho T, Hui J, Yamane A, Ukai S. (1993) Hypoglycemic activity and chemical properties of a polysaccharide from the cultural mycelium of Cordyceps sinensis. Biol Pharm Bull 1993 Dec; 16(12):1291-3.
Kiho T, Yamane A, Hui J, Usui S, Ukai S. (2000) Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Phytother Res 2000 Dec; 14(8):647-9.
Kuo, Y.C., Tsai, W.J., Shiao, M.S., Chen, C.F., and Lin, C.Y. (1996) Cordyceps sinensis as an immunomodulatary agent. American Journal of Chinese Medicine, 24:111-125.
Kuo, Y.C., Tsai, W.J., Wang , J.Y., Chang, S.C., Lin, C.Y., and Shiao, M.S. (2001). Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from Cordyceps sinensis. Life Sciences, 68:1067-1082.
Hawksworth D. L., et al. 1995 Ainsworth and Bisbi's Dictionary of the Fungi: 8th ed. International, University Press and Cambridge, 616 pp.
Hirose K., and Yahagi N. 1997. Japan tochukaso, Shock to Disappear of Cancer. Metamoru shyupan, Tokyo, 175 pp.
Itami H., and Yahagi N. 1996. Japan tochukaso, Challenge for Terminal Cancer. Metamoru shyupan, Tokyo, 140pp.Â
Jiang, JC, Gao, YF. Summary of treatment of 37 chronic renal disfunction patients with JinShuiBao. J Administration Traditional Chinese Med 1995; 5(suppl):23-24.
Kiho T., and Ukai S. 1995. Tochukaso (Semitake and others), Cordyceps species. Food Rev Int, 11, 231-234.Â
Kiho T., Hui, J., Yamane A., and Ukai S. 1993. Hypoglycemic activity and chemical properties of a polysaccharide from the cultural medium of Cordyceps sinensis. Bio Pharmacol Bull, 16:1291-1293.Â
Hiho T., Yamane A., Hui J., Usui S., and Ukai S. 1996. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Biol Pharmacol Bull, 19:294-296.
Kobayashi Y., and Shimizu D., 1983. Iconography of Vegetable Wasps and Plant Worms. Hoikusha Tokyo, 208 pp.
Kubo M. 1996 Tochukaso. Its secret and its Power. Hoikusha,, Tokyo, pp. 128, 152. Li, L.S. and Zheng, F. (1992). Clinical protection of aminoglycoside neophrotoxiciry by Cordyceps sinensis (CS). Journal of the American Society of Nephrology, 3:726 (ABSTRACT 24p).
Liu FA, Zheng X, (1993) Study of Cordyceps sinensis on anti-laryngeal carcinoma. J. Norman Bethune University Med Sci, 1993; 19(1):57-58.
Liu, C., Xue, HM., Xu, LM., Zhao, PZ., Zhang, LB., Tang, MG., Treatment of 22 patients with post hepatic cirrhosis with a preparation of fermented mycelia of Cordyceps sinensis. Shanghai J Chinese Materia Medica, 1986; 6:30-31.
Leung, A.K., Gong, F., and Chau, F. (2000). Analysis of the water soluble constituents of Cordyceps sinensis with heuristic evolving latent projections. Analytical Letters, 33:3195-3211.
The Merck Index, 11 Edition, 1989. 2524 Cordycepin. Merk and Co., 395 pp.
Mizuno T.1997. Development and ultilization of bioactive substances from medical and edible mushrooms fungi (10) Charga, Sclerotiana of Fuscopotia oblique (Fr) Aoshima. The Chemical Times, 163:9-15.Â
Mizuno T. 1998. Immunological Diet for Cancer Serious Disease. Gendaishorin, Tokyo, 188 pp.
Nakamura K, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M., Activation of in-vivo Kupffer cell function by oral administration of Cordyceps sinensis in rats. (1999) Jpn J Pharmacol, 1999 Apr;79(4):505-8.
Nakamura K, Konoha K, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M. (2003) Combined effects of Cordyceps sinensis and methotrexate on hematogenic lung metastasis in mice. Receptors Channels, 2003; 9(5):329-34 .
Ohmori T., Tamura K., Tsuru S., and Nomoto K., 1986. Antitumor activity of protein-blood polysaccharide from Cordyceps ophioglossoides in mice. Jnp J Cancer Res (Gann), 77:1256-1263.
Ohmori T., Tamura K., Furuki K., Kawanishi G., Mitsuyama M., Nomoto K., Miyazaki t, 1989. Isolation of galactosaminoglycan moity (CO-N) from protein-bound polysaccharide of Cordyceps ophioglossoides and its effects against murine tumor. Chem Pharmacol Bull, 37:1019-1022.
Parcell AC, Smith JM, Schulthies SS, Myrer JW, Fellingham G. (2004) Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004 Apr; 14(2):236-42.
Pelleg, A., Porter, R.S. (1990) The pharmacology of adenosine. Pharmacotherapy, 1990; 10:157-174.
Shin KH, Lim SS, Lee SH, Lee YS, Cho SY (2001) Antioxidant and immunostimulating activities of the fruiting bodies of Paecilomyces japonica, a new type of Cordyceps sp. Ann N Y Acad Sci. 2001 Apr; 928:261-73.
Shimizu D. 1994. Color Iconography of Vegetable Wasps and Plant Worms. Seibundoshinksosha, Tokyo, 381 pp.
Suh SO, Noda H, Blackwell M (2001)Insect symbiosis: derivation of yeast-like endosymbionts within an entomopathogenic filamentous lineage. Mol Biol Evol. 2001 Jun; 18(6):995-1000.
Takeuchi N. 1998. Pharmacological effect of Tochukaso and its utilization for food. Kagaku to Kogyo, 51:1614-161.
Toda, N., Okunishi, H., Taniyama, K., Miyazaki, M., (1982) Response to adenine nucleotides and related compounds of isolated dog cereberal, coronary and mesenteric arteries. Blood Vessels, 1982; 19:226-236.
Ukai S, Kiho T, Hara C, Morita M, Goto A, Imaizumi N, Hasegawa Y (1983) Polysaccharides in fungi: XIII. Antitumor activity of various polysaccharides isolated from Dictyophora indusiata, Ganoderma japonicum, Cordyceps cicadae, Auricularia uricula-judae and Auricularia sp. Chem Pharma Bull (Tokyo), 31:741-744.
Yamanaka K., and Inatomi S, 1997. Cultivation of Isaria japonica fruit bodies on mixed plant/insect media. Food Rev Int, 13:455-460.
Segelken, R. (2002) Cyclosporin mold's 'sexual state' found in New York forest Cornell students' discovery could target additional sources of nature-based pharmaceuticals Cornell University Science News, Sept 16, 1996.
Tai-Hao, H., Hui-Chen, L., Biological activity of Cordyceps (Fr.) Link Species (Ascomycetes) Derived from a Natural Source and from Fermented Mycelia on Diabetes in STZ-Induced Rats. Inter J of Med Mush, 4:111-125.
Xu, W.Z., Wei, J.P., Wang N. Q., Liu T., (1988) Experimental study of the combined chemotherapy of Zhiling Capsules and Anticancer agents. Shanghai Zhongyiyao Zazhi 1988; (6):48.
Xu, F., Huang JB., Jiang, L., Xu, J., Mi, J., (1995) Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney transplanted recipients. Nephrol Dial Transplant 1995; 10(1):142-143.
Yamada H., Kawaguchi N., Ohmori T., Takeshita Y., Teneya S., and Miyazaji t. 1984. Structure and antitumor activity if an alkali-soluble polysaccharide from Cordyceps ophioglossoides. Carbohydr Res, 125, 107-115.Â
Yamaguchi N., et al, (1990) Augmentation of various immune reactivities of tumor bearing hosts with an extract of Cordyceps sinensis. Biotherapy, 2:199-205.
Yang, YZ., Wang, LS., Deng, HY., Ma, YS., Wu, HS., Short term observation of treating chronic hepatitis B and post hepatic cirrhosis with XinGanBao. Res Chinese Materia Medica 1994; 1:19-20.Â
Yoshida J et al (1989) Antitumor activity of an extract of Cordyceps sinensis (Berk.) Sacc. Against murine tumor cell lines Jpn J Exp Med, 59:157-161.
Zhao CS, Yin WT, Wang JY, Zhang Y, Yu H, Cooper R, Smidt C, Zhu JS. (2002) Cordyceps Cs-4 improves glucose metabolism and increases insulin sensitivity in normal rats. J Altern Complement Med. 2002 Aug; 8(4):403-5.Â
Halpern, G., (1999) Cordyceps, Chinas healing mushroom. Avery Publishig 1999: 63-70 Bao, Z.D., Wu, Z.G., and Zheng, F. (1994). [Amelioration of aminoglycoside nephrotoxicity by Cordyceps Sinensis in old patients]. Chinese Journal of Integrated Medicine, 14:259,271-273.
Berne, R.M., 1980: The role of Adenosine in the regulation of coronary blood flow. Circ. Res. 1980; 47:807-813.
Wu T. N., Yang K. C., Wang C. M., Lai J. S., Ko K. N., Chang P. Y., and Liou S. H. 1996. Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: two case reports. Sci Total Environ, 182, 193-195.
|
